Adisseo(SH:600299) Zheng Quan Ri Bao Wang·2025-10-31 12:41Core Viewpoint - Blue Star Adisseo Co., Ltd. reported a stable revenue growth in Q3 2025, driven by increased penetration of liquid methionine and double-digit sales growth in specialty products, despite challenges from rising raw material prices and declining vitamin product prices [1][2]. Group 1: Financial Performance - For the first three quarters of 2025, the company achieved a revenue of RMB 12.931 billion, representing a year-on-year growth of 14% [1]. - Gross profit reached RMB 3.6 billion, showing a 4% increase compared to the same period last year [1]. - In Q3 2025, the company maintained stable revenue growth, with gross profit margins impacted by a sharp decline in vitamin prices and adverse tariff policies [1]. Group 2: Business Segments - The methionine business continued to grow, primarily due to the increasing global market penetration of liquid methionine and stable production at factories, leading to further optimization of supply chain costs [1]. - The solid methionine business contributed minimally to performance, mainly due to significant increases in raw material costs, particularly caustic soda [1]. - The specialty products segment saw a sales increase of 13% to RMB 1.14 billion, driven by strong sales growth in ruminant products in North America and Europe, particularly a 26% increase in sales of Starmine [2].